blinatumomab - CAS 853426-35-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C2367H3577N649O772S19
Molecular Weight:
54100
COA:
Inquire
Targets:
CD3, CD19
Description:
Blinatumomab is a monoclonal antibody used for the treatment of Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. It effects against tumor cells via binding to a CD3 site for T cells and a CD19 site for the target B cells, which express both in pediatric and adult populations.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
monoclonal antibody, Philadelphia chromosome-negative relapsed, refractory acute lymphoblastic leukemia
Synonyms:
Blincyto
MSDS:
Inquire
Application:
the treatment of Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia
Current Developer:
Amgen
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items